PRESS RELEASE published on 01/23/2026 at 08:00, 7 months 5 days ago Transgene Further Strengthens Scientific Advisory Board with Appointments of Renowned Cancer Immunotherapy Experts Antoine Italiano and Ignacio Melero Transgene strengthens Scientific Advisory Board with renowned cancer immunotherapy experts Prof. Antoine Italiano and Prof. Ignacio Melero. Appointment to accelerate development of myvac® platform and viral vector-based cancer vaccines Scientific Advisory Board Cancer Immunotherapy Transgene Antoine Italiano Ignacio Melero
PRESS RELEASE published on 01/23/2026 at 07:00, 7 months 5 days ago MANAGEMENT STATEMENT FOR THE THIRD QUARTER ENDED 31 DECEMBER 2025 Reinet Investments S.C.A. announces the results for the third quarter ended 31 December 2025 in a management statement. The company is listed on multiple stock exchanges Shareholders Quarter Results Investment Fund Luxembourg Stock Exchange Reinet Investments
PRESS RELEASE published on 01/23/2026 at 07:00, 7 months 5 days ago Mikron reports net sales of CHF 381.9 million for 2025 Mikron reports a 2.1% increase in net sales to CHF 381.9 million for 2025. Operating profit margin expected to be around 10.4%. Order backlog declines by 14.8% for 2026 Financial Results Net Sales Order Backlog Operating Profit Margin Mikron
PRESS RELEASE published on 01/23/2026 at 07:00, 7 months 5 days ago EQS-Adhoc: BB Biotech AG closes the 2025 fiscal year with a profit BB Biotech AG closes the 2025 fiscal year with a profit of approximately CHF 578 million, reflecting share price development. Full report on Feb 20, 2026 BB Biotech AG Profit 2025 Fiscal Year Share Price Development CHF 578 Million
PRESS RELEASE published on 01/23/2026 at 07:00, 7 months 5 days ago BB Biotech: Preliminary full-year 2025 results and dividend proposal BB Biotech AG reports strong full-year 2025 results with +34.2% total return in CHF, +37.0% in EUR, and +53.7% in USD, proposes dividend of CHF 2.25 per share at AGM on March 19, 2026 Dividend Proposal Stock Market Full-year Results BB Biotech AG 2025 Performance
PRESS RELEASE published on 01/23/2026 at 07:00, 7 months 5 days ago VALLOUREC TO SHOWCASE DELPHY, ITS INNOVATIVE HYDROGEN STORAGE SOLUTION, AT HYVOLUTION 2026 Vallourec to showcase Delphy, its innovative hydrogen storage solution, at Hyvolution 2026. Delphy awarded Innovation Prize. Event provides platform for green hydrogen solutions Innovation Award Hydrogen Storage Vallourec Delphy Hyvolution 2026
PRESS RELEASE published on 01/23/2026 at 07:00, 7 months 5 days ago Press Release: Sanofi's amlitelimab confirms its potential in atopic dermatitis Sanofi's amlitelimab shows potential in atopic dermatitis with positive results in SHORE and COAST 2 phase 3 studies. Global regulatory submissions planned Sanofi Phase 3 Study Atopic Dermatitis Global Regulatory Submissions Amlitelimab
PRESS RELEASE published on 01/23/2026 at 06:46, 7 months 5 days ago GURIT REPORTS NET SALES OF CHF 319.6 MILLION FOR THE CALENDAR YEAR 2025 AND EXPECTS MARGIN TO IMPROVE VERSUS 2024. Gurit reports preliminary net sales of CHF 319.6 million for 2025, driving progress in transformation and securing contracts with strategic customers. Margin expected to improve in 2026 Net Sales Transformation 2025 Margin Gurit
PRESS RELEASE published on 01/23/2026 at 06:40, 7 months 5 days ago HBM Healthcare Investments publishes Quarterly Report as at 31 December 2025 with key figures for the first nine months of the 2025/2026 financial year HBM Healthcare Investments publishes positive Q3 results, with CHF 191 million profit, 18% NAV increase, and new private company investments Financial Results HBM Healthcare Investments Quarterly Report Investments Biotechnology Sector
PRESS RELEASE published on 01/23/2026 at 06:28, 7 months 5 days ago SFS generates solid organic growth in 2025 SFS Group achieved 2.9% organic growth in 2025, reaching CHF 3,056.6 million in sales despite -2.9% currency effects Sales Financial Year Organic Growth Currency Effects SFS Group
Published on 08/28/2026 at 14:00, 2 hours 59 minutes ago Lobe Sciences Expands Leadership Team with New CFO Appointment
Published on 08/28/2026 at 13:00, 3 hours 59 minutes ago Abasca Files NI 43-101 Technical Report, Commences Summer Exploration Program at Loki and Elects to File Semi-annual Interim Financial Statements and Related MD&A
Published on 08/28/2026 at 08:05, 8 hours 54 minutes ago Caledonia Mining Corporation Plc: Maiden Mineral Resource Estimate at Motapa 379,000 oz Measured and Indicated; 131,000 oz Inferred
Published on 08/28/2026 at 08:05, 8 hours 54 minutes ago Tocvan Announces New Surface Mineralization in Several Zones at Gran Pilar Gold-Silver Project
Published on 08/28/2026 at 08:00, 8 hours 59 minutes ago Caledonia Mining Corporation Plc: Blanket Mine Underground Measured and Indicated Mineral Resources Estimate Increases by 22% to 2.18 Million Ounces and Declaration of a Surface Mineral Resource Estimate
Published on 08/28/2026 at 15:55, 1 hour 3 minutes ago Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.
Published on 08/28/2026 at 15:55, 1 hour 4 minutes ago Form 8.3 - The Vanguard Group, Inc.: DNO Iraq AS (a wholly owned subsidiary of DNO ASA)
Published on 08/28/2026 at 15:54, 1 hour 4 minutes ago Viromed Medical AG receives ÜTS registration for ViroCAP® in Turkey and can fulfill existing orders
Published on 08/26/2026 at 18:02, 1 day 22 hours ago Altareit: Altarea press release regarding the Primonial matter
Published on 08/26/2026 at 18:00, 1 day 22 hours ago Altarea: Comprehensive settlement agreement reached, ending the dispute between Altarea and the shareholders of the Praemia group (formerly Primonial group)
Published on 08/25/2026 at 17:45, 2 days 23 hours ago CEGEDIM: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS